1. Home
  2. FBLG

as 05-29-2024 12:33pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Founded: 2021 Country:
United States
United States
Employees: N/A City: HOUSTON
Market Cap: 375.6M IPO Year: 2024
Target Price: N/A AVG Volume (30 days): 70.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.69 EPS Growth: N/A
52 Week Low/High: $6.53 - $46.00 Next Earning Date: 05-14-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: